The American Association for Cancer Research is inviting applications for the Clinical Oncology Research Training Fellowships program, which is designed to provide an effective industry-academic clinical practicum with a unique training opportunity in the area of drug development.
Fellowships provide support of $100,000 over a twelve-month period for fellows to work on site at the facility of one of AACR’s pharmaceutical industry partners. Time to be spent at the industry site can be flexible and is determined by mutual agreement between the selected fellow, the fellow’s institution, and the industry partner. In addition, a limited stipend of up to $7,500 may be provided to cover necessary costs for the fellow to travel to and from the industry site.
Fellows will be provided with real-world experience in clinical development, including drug development, clinical research, trial design, and data analysis. Fellows will be accountable for executing clinical research project(s) and completing the research within their one-year program, and opportunities for publication and presentation of the research will be provided.
Industry partners for this program and their research areas include the following:
Agenus (Lexington, Massachusetts) — Clinical development of a pipeline of novel immune therapies.
AstraZeneca (Gaithersburg, Maryland) — Early-stage and late-stage clinical development in immune-oncology.
Bayer Healthcare (Cambridge, Massachusetts) — Early-stage and/or late-stage clinical development in oncology.
To be eligible, applicants must be a member of AACR; have a medical degree (MD, DO, or MD/PhD) in a related field, and not currently be a candidate for a further doctoral degree; and have enrolled in an accredited hematology/oncology or radiation oncology fellowship program at an academic, medical, or research institution within the United States
See the American Association for Cancer Research website for complete program guidelines and application instructions.